New metabolic vulnerabilities of subsets of triple-negative breast cancer discovered
 

Researchers have identified a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients, which they hope could serve as a biomarker to select patients to receive targeted therapy.

More...